CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,000 | -10.0% | 20,650 | +3.4% | 0.00% | – |
| Q2 2018 | $10,000 | -89.2% | 19,971 | -50.3% | 0.00% | – |
| Q1 2018 | $93,000 | -11.4% | 40,143 | +8.8% | 0.00% | – |
| Q4 2017 | $105,000 | +128.3% | 36,909 | +131.8% | 0.00% | – |
| Q3 2017 | $46,000 | -2.1% | 15,923 | -16.5% | 0.00% | – |
| Q2 2017 | $47,000 | -9.6% | 19,080 | +33.2% | 0.00% | – |
| Q1 2017 | $52,000 | -10.3% | 14,325 | -12.5% | 0.00% | – |
| Q4 2016 | $58,000 | -12.1% | 16,369 | 0.0% | 0.00% | – |
| Q3 2016 | $66,000 | -8.3% | 16,369 | 0.0% | 0.00% | – |
| Q2 2016 | $72,000 | +10.8% | 16,369 | -5.0% | 0.00% | – |
| Q1 2016 | $65,000 | -75.7% | 17,234 | +1.3% | 0.00% | – |
| Q4 2015 | $267,000 | +51.7% | 17,020 | +2.0% | 0.00% | – |
| Q3 2015 | $176,000 | -48.2% | 16,692 | +23.8% | 0.00% | -100.0% |
| Q2 2015 | $340,000 | -5.6% | 13,483 | +4.4% | 0.00% | 0.0% |
| Q1 2015 | $360,000 | +50.6% | 12,909 | -1.3% | 0.00% | – |
| Q4 2014 | $239,000 | +24.5% | 13,075 | -11.9% | 0.00% | – |
| Q3 2014 | $192,000 | -20.7% | 14,849 | 0.0% | 0.00% | – |
| Q2 2014 | $242,000 | -48.0% | 14,849 | -43.5% | 0.00% | -100.0% |
| Q1 2014 | $465,000 | -27.1% | 26,298 | -0.1% | 0.00% | 0.0% |
| Q4 2013 | $638,000 | -31.7% | 26,333 | -0.2% | 0.00% | -50.0% |
| Q3 2013 | $934,000 | +140.7% | 26,374 | +6.1% | 0.00% | +100.0% |
| Q2 2013 | $388,000 | – | 24,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |